Explore current portfolio

Ultra-high concentration microparticle suspension technology

Elektrofi is a biopharmaceutical formulation technology company revolutionising the delivery of biologic therapies. Breakthrough ultra-high concentration microparticle technology platform resolves the limitations associated with intravenously biologic therapies. With a focus on monoclonal antibodies, therapeutic proteins, and other large molecule drugs, Elektrofi creates, develops, and commercialises subcutaneous biologic therapies in collaboration with strategic partners.

Nanomaterials for drug delivery applications

Vector-Bioscience focuses on nanoparticles as drug delivery vehicles. Facilitating drug delivery with lower toxicity, target delivery and an improved shelf-life of RNA treatments. Proprietary MOF solutions produce 10x uptake and slow-release, avoiding burst effect while providing a targeted delivery. Targeted MOFs will offer a high local concentration in the tumours, minimising side-effects. MOF encapsulation produces stable formulations and no degradation even at room temperature. Vectors technology is a Cargo agnostic, plug-and-play platform.

Spectral signature authentication technology

TruTag Technologies developed the most effective product authentication and brand protection solution; addressing the trillion-dollar problem of counterfeit and diverted goods in supply chains. The company develops innovative, cost-effective and practical solutions using TruTag® microtags (“TruTags®”) made of silicon dioxide, or silica. Turning every product into a data point. Giving pharmaceutical companies the power to scan a pill found anywhere in the world and immediately confirm its authenticity.

Medicine discovery platform for autoimmune disease

Discovery platform is based on research that the metabolic state of activated immune cells is highly dependent upon their environment during disease onset. Octagon directly uses a large clinical sample collection from patients with autoimmune disease as part of a proprietary discovery approach. Octagon has developed an approach that enables targeted inhibition of specific cell populations during active disease.

Portable brain scanner technology

Traumatic brain injury is the leading cause of death and disability among the under 40s. Cortirio’s portable scanners can be used at the point of care to rapidly diagnose and monitor traumatic brain injuries. Saving time saves brain function, preventing disability and death.